Rhode Island Public Radio recently hosted a series of informative radio segments on hepatitis C. We continue sharing this series with Part Five: The Uncomfortable Math of Hep C Treatment. The series covers a range of topics relevant to both patients and providers, including infection statistics, populations at highest risk, the newest pharmaceuticals designed to combat hepatitis C, and barriers for patients attempting to access treatment. Click here to listen to Part Five of At the Crossroads.
What’s the price of a human life? Many of us would say each life is priceless. But health economists sometimes have a number in mind.
Want to know what that number is?
In this part of our series “At the Crossroads: The Rise of Hepatitis C and The Fight To Stop It,” we’ll tell you that – and more. We go beyond the high price of new hepatitis C drugs to ask: how much is too much? And what the heck is a “quality adjusted life year” anyway?
If you are a person living with hepatitis C and have questions after reading this article or listening to the public radio broadcast, please call our helpline at 1-800-522-HEPC (4372).